HCAT
Health Catalyst, Inc.
Set alert
- YTD
- -29.29%
- 1 year
- -48.48%
- Open
- 1.79
- Prev close
- 1.79
- Mkt cap
- 127.18M
- Vol
- 344.99K
- Avg vol
- 590.89K
- EPS
- -3.69
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 1.66
- High
- 1.84
- Forward P/E
- 16.52
- Beta
- 1.32
- Short ratio
- 5.03
- Inst. own
- 90.64%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 7, 2024
- 50-d avg
- 8.10
- 200-d avg
- 7.27
- 1y target
- 11.41
Key statistics
- Market cap
- 422.28M
- Enterprise value
- 408.49M
- Trailing P/E
- 0.00
- Forward P/E
- 16.52
- PEG ratio
- 0.00
- Price / sales
- 1.40
- Price / book
- 1.19
- EPS (TTM)
- -1.34
- Beta
- 1.32
- Dividend yield
- 0.00%
- Payout ratio
- 0.00%
- Profit margin
- -26.20%
- Revenue (TTM)
- 302.06M
- Revenue growth
- 3.50%
- Free cash flow
- 24.03M
- Total cash
- 387.26M
- Total debt
- 364.33M
- Return on equity
- -21.46%
- Shares outstanding
- 60.85M
- Short % of float
- 4.28%
- 50-day average
- 8.10
- 200-day average
- 7.27
Analyst view
Consensus: none
- Target (low)
- 9.00
- Target (mean)
- 11.41
- Target (high)
- 16.00
- Strong buy2
- Buy7
- Hold5
- Sell0
- Strong sell0
Next earnings
Aug 7, 2024
Expected Aug 7, 2024. Consensus EPS estimate 0.07649.
Financials — quick view
Earnings
| Report date | Quarter ending | EPS estimate | EPS reported | Surprise | Surprise % |
|---|---|---|---|---|---|
| Nov 6, 2024 | Sep 1, 2024 | 0.10 | 0.07 | -0.03 | -30.00% |
| Aug 7, 2024 | Jun 1, 2024 | 0.09 | 0.12 | +0.03 | +33.33% |
| Aug 7, 2024 | Jun 1, 2024 | 0.09 | — | — | — |
| May 9, 2024 | Mar 1, 2024 | 0.03 | 0.05 | +0.02 | +66.67% |
| May 9, 2024 | Mar 1, 2024 | 0.03 | — | — | — |
| Feb 22, 2024 | Dec 1, 2023 | -0.01 | 0.02 | +0.03 | +300.00% |
Upgrades / downgrades
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Nov 26, 2024 | Piper Sandler | reit | Overweight | Overweight |
| Nov 14, 2024 | Stephens & Co. | main | Equal-Weight | Equal-Weight |
| Nov 13, 2024 | Citigroup | main | Buy | Buy |
| Nov 7, 2024 | RBC Capital | main | Sector Perform | Sector Perform |
| Oct 8, 2024 | Evercore ISI Group | main | Outperform | Outperform |
| Oct 4, 2024 | Cantor Fitzgerald | reit | Overweight | Overweight |
About Health Catalyst, Inc.
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.
- Sector
- Healthcare
- Industry
- Health Information Services
- Country
- United States
- Website
- healthcatalyst.com
News
- Health Catalyst to Announce Third Quarter 2026 Operating Results and Host Conference Call on Thursday, November 5, 2026
- Health Catalyst Reports Q2 2026 Results: Full Earnings Call Transcript
- Health Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
- Health Catalyst Strengthens Its Board with the Appointment of Tami Reller
- Health Catalyst Appoints Simeon Kohl as Chief Executive Officer and President
- Hsbc Holdings PLC Invests $809,000 in Health Catalyst, Inc. $HCAT
- Health Catalyst to Participate in Upcoming Investor Conference
- Critical Survey: Aclarion (NASDAQ:ACONW) and Health Catalyst (NASDAQ:HCAT)
- This Teradyne Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Friday
- Canaccord Genuity Downgrades Health Catalyst to Hold, Lowers Price Target to $1.8
Your note
Sign in to keep a note on HCAT — it syncs with the Stock Master app.
Insider holders
| Insider | Relation | Latest transaction | Date | Shares held |
|---|---|---|---|---|
| ALGER JASON | Chief Financial Officer | Sale | Dec 5, 2024 | 86,712 |
| FREEMAN KEVIN LEE | Officer | Sale | Dec 1, 2024 | 236,950 |
| GALLAGHER DUNCAN P | Director | Stock Award(Grant) | Nov 28, 2024 | 78,938 |
| HOGGARD GREEN JILL | Director | Stock Award(Grant) | Nov 28, 2024 | 27,706 |
| KANE JOHN A | Director | Stock Award(Grant) | Jun 12, 2024 | 130,995 |
| LANDRY BENJAMIN | General Counsel | Sale | Dec 5, 2024 | 72,250 |
Institution ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Blackrock Inc. | 9.10% | 5,538,109 | 38.43M | Sep 29, 2024 |
| Vanguard Group Inc | 7.53% | 4,580,563 | 31.79M | Sep 29, 2024 |
| First Light Asset Management, LLC | 7.06% | 4,296,490 | 29.82M | Sep 29, 2024 |
| Impax Asset Management Group Plc | 4.20% | 2,554,475 | 17.73M | Sep 29, 2024 |
| Daventry Group, LP | 3.97% | 2,417,602 | 16.78M | Sep 29, 2024 |
| Primecap Management Company | 3.95% | 2,404,462 | 16.69M | Sep 29, 2024 |
Fund ownership
| Holder | % held | Shares | Value | Reported |
|---|---|---|---|---|
| Pax World Small Cap Fund | 4.20% | 2,554,475 | 17.73M | Sep 29, 2024 |
| Primecap Odyssey Aggressive Growth Fund | 3.49% | 2,124,406 | 14.74M | Sep 29, 2024 |
| Vanguard Total Stock Market Index Fund | 2.99% | 1,822,128 | 12.65M | Sep 29, 2024 |
| iShares Russell 2000 ETF | 2.47% | 1,505,112 | 10.45M | Oct 30, 2024 |
| Vanguard Extended Market Index Fund | 1.56% | 949,750 | 6.59M | Sep 29, 2024 |
| American Beacon Small Cap Value Fd | 1.04% | 633,459 | 4.40M | Oct 30, 2024 |